MENICON CO.LTD

Research MENICON CO.LTD (5FR) on Bullrun: valuation model: 11.7% overvalued, market cap EUR 615.83M, P/E 24.4, dividend yield 1.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker5FR
ExchangeF
CountryJapan
SectorHealthcare
IndustryMedical Instruments & Supplies
CurrencyEUR
Valuation signal11.7% overvalued
Market capEUR 615.83M
P/E24.4
Dividend yield1.8%
Financial periodFY2025
RevenueEUR 121.49B
Revenue growth4.6%
Net incomeEUR 5.62B
Free cash flow-EUR 3.54B
Gross margin53.6%

Valuation Snapshot

Bullrun's latest valuation model marks MENICON CO.LTD as 11.7% overvalued; latest market cap is EUR 615.83M; P/E is 24.4; dividend yield is 1.8%.

About MENICON CO.LTD

Menicon Co., Ltd. manufactures and sells contact lenses and lens care products in Japan. The company offers its products to hospitals, eye clinics, contact lens retailers, eyeglass stores, and drug stores. It also exports its products. Menicon Co., Ltd. was incorporated in 1943 and is headquartered in Nagoya, Japan.

Frequently asked questions

Is MENICON CO.LTD overvalued or undervalued?

Bullrun's valuation model currently marks MENICON CO.LTD as 11.7% overvalued.

What is MENICON CO.LTD's market cap?

MENICON CO.LTD's market capitalization is EUR 615.83M.

What is MENICON CO.LTD's P/E ratio?

MENICON CO.LTD's price-to-earnings (P/E) ratio is 24.4.

Does MENICON CO.LTD pay a dividend?

MENICON CO.LTD has a dividend yield of 1.8%.